CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 116 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,352,481 | +518.5% | 158,157 | +662.6% | 0.00% | – |
| Q2 2023 | $703,708 | +28954.8% | 20,740 | -61.8% | 0.00% | -100.0% |
| Q4 2022 | $2,422 | -100.0% | 54,351 | -79.1% | 0.00% | -75.0% |
| Q2 2022 | $6,998,000 | +90.8% | 259,543 | +141.0% | 0.00% | +100.0% |
| Q1 2022 | $3,668,000 | +139.3% | 107,701 | +171.5% | 0.00% | +100.0% |
| Q4 2021 | $1,533,000 | -85.3% | 39,671 | -92.1% | 0.00% | -85.7% |
| Q1 2021 | $10,406,000 | +188.4% | 505,163 | +145.3% | 0.01% | +133.3% |
| Q4 2020 | $3,608,000 | -39.9% | 205,922 | -55.4% | 0.00% | -66.7% |
| Q2 2020 | $6,003,000 | – | 461,764 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |